Projekt 1 2024 - Lymphoma Challenge

Project

24–01

Status:

Running

Start:

21.09.2020–09.02.2023

Team L-R: Titel Vorname Name , Titel Vorname Name

Projekt 1 2024

Project

24–01

Projekt 1 2024

Status:

Running

Start:

21.09.2020–09.02.2023

Team L-R: Titel Vorname Name , Titel Vorname Name

Institutions  involved

Our expertise

Schreib einen Titel

Our expertise

Schreib einen Titel

Publications

link =

Project leader

Titel Name Vorname

ETH Zürich

Wirkungsorte und Icon-Link als Code am Ende des Textes $

Titel Name Vorname

Clinic institution

Wirkungsorte und Icon-Link als Code am Ende des Textes $

Project leader

Titel Name Vorname

ETH Zürich

Wirkungsorte und Icon-Link als Code am Ende des Textes $

Titel Name Vorname

Clinic institution

Wirkungsorte und Icon-Link als Code am Ende des Textes $

You are currently at project

24–01

21–01

Effector-target cell interactions in engineered immune-therapy against hematologic malignancies

Prof. Dr. Timm Schroeder

ETH Zurich

Prof. Dr. med. Markus G. Manz

University Hospital Zurich

21–02

Understanding how clonal hematopoiesis feeds lymphoma

Prof. Dr. med. Andrea Alimonti

ETH Zurich

Prof. Dr. med. Emanuele Zucca

Ente Ospedaliero Cantonale (EOC) / Oncology Institute of Southern Switzerland (IOSI)

21–03

Overcoming the challenge of T-cell lymphoma treatment by safe and efficacious anti-CD30 radioimmunotherapy with β-particle and ultra-short range Auger and conversion electron emitting radionuclides

Prof. Dr. Roger Schibli

ETH Zurich

Prof. Dr. med. Urban Novak

Inselspital / University Hospital Bern

22–01

Exploring the potential of targeting IL-21/IL-21R signaling to eliminate human acute myeloid leukemia stem cells

Prof. Dr. Manfred Kopf

ETH Zurich

Prof. Dr. Carsten Riether

Inselspital & University of Bern

22–02

Regulatory T-cells as tumor-promoting cellular partners and potential therapeutic targets in diffuse large B-cell lymphoma

Prof. Dr. Nicola Aceto

ETH Zurich

Prof. Dr. Alexandar Tzankov

University Hospital Basel

23–01

Harnessing gut microbiome metabolism for personalized treatment of lymphoma and leukemia

Prof. Dr. Nicholas Bokulich

ETH Zurich

Prof. Dr. med. Jörg Halter

University Hospital Basel